APA (7th ed.) Citation

Ciérvide, R., Montero, Á., García-Rico, E., García-Aranda, M., Herrero, M., Skaarup, J., . . . Prieto, M. (2022). Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination. Cancers, 14(18), N.PAG. https://doi.org/10.3390/cancers14184531

Chicago Style (17th ed.) Citation

Ciérvide, Raquel, et al. "Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination." Cancers 14, no. 18 (2022): N.PAG. https://doi.org/10.3390/cancers14184531.

MLA (9th ed.) Citation

Ciérvide, Raquel, et al. "Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination." Cancers, vol. 14, no. 18, 2022, p. N.PAG, https://doi.org/10.3390/cancers14184531.